Antiviral and host response studies on Junin hemorrhagic fever virus using global gene expression profiles and qRT-PCR (original) (raw)

TRAIL Is a Novel Antiviral Protein against Dengue Virus

Irene Bosch

Journal of Virology, 2008

View PDFchevron_right

Understanding the Dengue Viruses and Progress towards Their Control

Ernest Gould

BioMed Research International, 2013

View PDFchevron_right

Current Understanding of the Pathogenesis of Dengue Virus Infection

Govindakarnavar Arunkumar

Current Microbiology

View PDFchevron_right

Development of Stable Cell Line for NS3 Gene of Dengue Virus and Screening of Antiviral Compounds

Farkhanda Yasmin

2018

View PDFchevron_right

Interferon lambda inhibits dengue virus replication in epithelial cells

Veronica Vallejo-ruiz

Virology Journal, 2015

View PDFchevron_right

Predicting The Possible Biological Markers as Targeted Therapy for Dengue Viral Infections

Arief Hidayatullah

Malaysian Journal of Biochemistry & Molecular Biology, 2021

View PDFchevron_right

Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis

Yeneiris Villero Wolf

View PDFchevron_right

Dengue Virus Induces Novel Changes in Gene Expression of Human Umbilical Vein Endothelial Cells

Irene Bosch

Journal of Virology, 2003

View PDFchevron_right

Modulation of Dengue Virus Infection in Human Cells by Alpha, Beta, and Gamma Interferons

Dianna Edgil

Journal of Virology, 2000

View PDFchevron_right

Targeting a host process as an antiviral approach against dengue virus

Nicole Zitzmann

Trends in Microbiology, 2010

View PDFchevron_right

Insight into the Tropism of Dengue Virus in Humans

Sandeepan Das

Viruses

View PDFchevron_right

Dengue virus: epidemiology, biology, and disease aetiology

Soumen Bhattacharjee

Canadian Journal of Microbiology

View PDFchevron_right

Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model

Korin Eckstrom

Nature Communications

View PDFchevron_right

Inhibition of Dengue Virus Entry and Multiplication into Monocytes Using RNA Interference

Shamala Devi Sekaran

Plos Neglected Tropical Diseases, 2011

View PDFchevron_right

Dengue Virus Infection Differentially Regulates Endothelial Barrier Function over Time through Type I Interferon Effects

Francis Ennis

The Journal of Infectious Diseases, 2009

View PDFchevron_right

A Host-Oriented Inhibitor of Junin Argentine Hemorrhagic Fever Virus Egress

Gordon Ruthel

Journal of Virology, 2014

View PDFchevron_right

Cyclooxygenase‐2 facilitates dengue virus replication and serves as a potential target for developing antiviral agents

Chih-Chuang Liaw

Scientific Reports, 2017

View PDFchevron_right

Inhibition of Dengue Virus Infections in Cell Cultures and in AG129 Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence

Matthew Fischer

Journal of Virology, 2011

View PDFchevron_right

Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor

Susana Orozco

Journal of General Virology, 2012

View PDFchevron_right

An iminosugar with potent inhibition of dengue virus infection in vivo

Raymond Dwek

Antiviral Research, 2013

View PDFchevron_right

UPDATES ON DENGUE PATHOGENESIS (2015)

Tanya Grace Gonzales

View PDFchevron_right

RNA Interference Mediated Inhibition of Dengue Virus Multiplication and Entry in HepG2 Cells

Shamala Devi Sekaran

Plos One, 2012

View PDFchevron_right

Activation of TNF α, IL1-β and Type-I IFN Pathways in human umbilical vein endothelial cells During Dengue 2 Virus Infection

Irene Bosch

2002

View PDFchevron_right

Dengue Virus: Clinical Manifestations and Advances in Diagnosis, Treatment with a Special Focus on Strategies to Limit Mosquito Spread

JISSIN MATHEW

Journal of Pure and Applied Microbiology, 2019

View PDFchevron_right

Imunocompetent Mice Model for Dengue Virus Infection

Denise Gonçalves

The Scientific World Journal, 2012

View PDFchevron_right

Randomized, Placebo-Controlled Trial of Nonpegylated and Pegylated Forms of Recombinant Human Alpha Interferon 2a for Suppression of Dengue Virus Viremia in Rhesus Monkeys

Montip Gettayacamin

Antimicrobial Agents and Chemotherapy, 2005

View PDFchevron_right